PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Pulmatrix, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.42+0.06 (+4.41%)
Close on Oct 19, 2026
- Market cap
- $5.19M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$3.39 (−70.50%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $5.19M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.03
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$4.01M
- EPS, diluted
- -$1.10
- Book value per share
- $0.70
- Diluted shares
- 4M
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$4.11M
Net income
-$4.01M
EPS, diluted
-$1.10
Free cash flow
–
Reported periodTrailing twelve months